In the News

Melinda Aldrich, PhD, MPH, associate professor of Medicine in the Division of Genetic Medicine, has been elected to the Board of Directors of the American Society of Human Genetics (ASHG). Her three-year term will begin on Jan. 1, 2025.

The new study identifies 4,248 CpG sites associated with the risk of seven different types of cancer: breast, colorectal, renal cell, lung, ovarian, prostate and testicular germ cell cancers.

Vanderbilt University Medical Center investigators have received a five-year, $1.25 million grant from the Fogarty International Center, part of the National Institutes of Health, to build expertise in genetic epidemiology research in Vietnam.